← Open Payments lookup

ALLISON PULLEN: Open Payments

NPI 1477915742 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,205 in 63 payments from 12 companies in 2025. Trend: 2023 $488 · 2024 $1,162 · 2025 $2,205

Food & beverage: $2,205
CompanyPaymentsAmount
Madrigal Pharmaceuticals16$546
Ipsen Biopharmaceuticals, Inc11$376
Gilead Sciences, Inc.11$297
Janssen Biotech, Inc.2$272
Novo Nordisk Inc3$183
Mallinckrodt Hospital Products Inc.5$159
Salix Pharmaceuticals, a division of Bausch Health US, LLC8$135
Janssen Scientific Affairs, LLC2$121
Mirum Pharmaceuticals, Inc.2$45
Lilly USA, LLC1$31

Products named: REZDIFFRA, TREMFYA, IQIRVO, Wegovy, TERLIVAZ, XIFAXAN, Livdelzi, Livmarli.

Industry payments across MD — which companies pay providers there.